BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25993292)

  • 1. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.
    Yoshimura K; Nagasawa A; Kudo J; Onoda M; Morikage N; Furutani A; Aoki H; Hamano K
    Int J Mol Sci; 2015 May; 16(5):11213-28. PubMed ID: 25993292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB.
    Piechota-Polanczyk A; Goraca A; Demyanets S; Mittlboeck M; Domenig C; Neumayer C; Wojta J; Nanobachvili J; Huk I; Klinger M
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):133-7. PubMed ID: 22694979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
    Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
    Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
    Nagashima H; Aoka Y; Sakomura Y; Sakuta A; Aomi S; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
    J Vasc Surg; 2002 Jul; 36(1):158-63. PubMed ID: 12096274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
    Wilson WR; Evans J; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
    Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm.
    Pini R; Ciavarella C; Faggioli G; Gallitto E; Indelicato G; Fenelli C; Mascoli C; Vacirca A; Gargiulo M; Pasquinelli G
    Ann Vasc Surg; 2020 Aug; 67():490-496. PubMed ID: 32173476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
    Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
    Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
    Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
    Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoidan attenuates angiotensin II-induced abdominal aortic aneurysms through the inhibition of c-Jun N-terminal kinase and nuclear factor κB activation.
    Tsai SH; Wang JC; Liao WI; Hsu YJ; Lin CY; Liao MT; Huang PH; Lin SJ
    J Vasc Surg; 2018 Dec; 68(6S):72S-81S.e1. PubMed ID: 29290496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
    Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
    Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway.
    Yan YW; Fan J; Bai SL; Hou WJ; Li X; Tong H
    PLoS One; 2016; 11(2):e0148536. PubMed ID: 26918963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm.
    Piechota-Polanczyk A; Demyanets S; Nykonenko O; Huk I; Mittlboeck M; Domenig CM; Neumayer C; Wojta J; Nanobachvili J; Klinger M
    Eur J Vasc Endovasc Surg; 2013 Jun; 45(6):682-8. PubMed ID: 23558220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK.
    Zhang Y; Naggar JC; Welzig CM; Beasley D; Moulton KS; Park HJ; Galper JB
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1764-71. PubMed ID: 19729613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Timp1 in smooth muscle cells during development of abdominal aortic aneurysms.
    Bumdelger B; Kokubo H; Kamata R; Fujii M; Ishida M; Ishida T; Yoshizumi M
    Hiroshima J Med Sci; 2013 Sep; 62(3):63-7. PubMed ID: 24279124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells.
    Jiang JL; Wang S; Li NS; Zhang XH; Deng HW; Li YJ
    Biochem Cell Biol; 2007 Feb; 85(1):66-77. PubMed ID: 17464346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
    Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
    J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.